山东大学耳鼻喉眼学报 ›› 2017, Vol. 31 ›› Issue (6): 16-20.doi: 10.6040/j.issn.1673-3770.1.2017.040

• 甲状腺癌的规范化诊断与治疗·专题笔谈 • 上一篇    下一篇

甲状腺未分化癌的规范化治疗

孙滨,郭伯敏,康杰,邓先兆,伍波,樊友本   

  1. 上海交通大学附属第六人民医院普外科, 上海交通大学甲状腺疾病诊治中心, 上海 200233
  • 收稿日期:2017-10-10 出版日期:2017-12-16 发布日期:2017-12-16
  • 通讯作者: 樊友本. E-mail:fanyouben2006@163.com
  • 基金资助:
    国家自然科学基金(81670718)

Standardization of the diagnosis and treatment of anaplastic thyroid carcinoma.

SUN Bin, GUO Bomin, KANG Jie, DENG Xianzhao, WU Bo, FAN Youben   

  1. Shanghai Jiao Tong University Affiliated Sixth Peoples Hospital General Surgery, Shanghai Jiaotong University Thyroid Disease Diagnosis and Treatment Center, Shanghai 200233, China
  • Received:2017-10-10 Online:2017-12-16 Published:2017-12-16

摘要: 甲状腺未分化癌是恶性程度最高的甲状腺肿瘤,侵袭性高,转移早,预后极差。目前临床上采用手术、放疗、化疗及靶向治疗等方式进行综合治疗,但尚未有十分有效的规范化治疗方案,结合该院诊治经验,探索甲状腺未分化癌的规范化治疗。

关键词: 规范化, 治疗, 甲状腺未分化癌

Abstract: Anaplastic thyroid carcinoma(ATC)is the most aggressive malignant thyroid carcinoma, with rapid metastasis and high mortality rates. In clinical settings, surgery, radiotherapy, chemotherapy, and targeted therapy have been applied for comprehensive treatment. Till date, there is no standardized effective treatment. Herein, we present the “standardization” of the diagnosis and treatment of ATC based on our own clinical experience.

Key words: Standardization, Anaplastic thyroid carcinoma, Treatment

中图分类号: 

  • R736.1
[1] Kebebew E, Greenspan FS, Clark OH, et al. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors[J]. Cancer, 2005,103(7):1330-1335.
[2] Wendler J, Kroiss M, Gast K, et al. Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in germany[J]. Eur J Endocrinol, 2016, 175(6):521-529.
[3] Segerhammar I, Larsson C, Nilsson IL, et al. Anaplastic carcinoma of the thyroid gland: treatment and outcome over 13 years at one institution[J]. J Surg Oncol, 2012, 106(8):981-986.
[4] Smallridge RC, Ain KB, Asa SL, et al. American thyroid association guidelines for management of patients with anaplastic thyroid cancer[J]. Thyroid, 2012, 22(11):1104-1139.
[5] Haddad RI, Lydiatt WM, Ball DW, et al. Anaplastic thyroid carcinoma, version 2.2015[J]. J Natl Compr Canc Netw, 2015, 13(9):1140-1150.
[6] Zivaljevic V, Tausanovic K, Paunovic I, et al. Age as a prognostic factor in anaplastic thyroid cancer[J]. Int J Endocrinol, 2014: 240513.
[7] Akaishi J, Sugino K, Kitagawa W, et al. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma[J]. Thyroid, 2011, 21(11):1183-1189.
[8] Sugitani I, Miyauchi A, Sugino K, et al. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: Atc research consortium of japan cohort study of 677 patients[J]. World J Surg, 2012, 36(6):1247-1254.
[9] Yoshida A, Matuzu K. Analysis of long-term survivors in anaplastic thyroid carcinoma[J]. Nihon Geka Gakkai Zasshi, 2012, 113(4):373-377.
[10] Sugitani I, Hasegawa Y, Sugasawa M, et al. Super-radical surgery for anaplastic thyroid carcinoma: a large cohort study using the anaplastic thyroid carcinoma research consortium of japan database[J]. Head Neck, 2014, 36(3):328-333.
[11] 张宗敏, 徐震纲, 唐平章, 等. 重新认识甲状腺未分化癌[J]. 中国医学科学院学报, 2006,28(3):322-324. ZHANG Zongmin, XU Zhengang, TANG Pingzhang, et al. A retrospective analysis of anaplastic thyroid carcinoma[J]. Act Acad Med Sin, 2006, 28(3):322-324.
[12] Pierie JP, Muzikansky A, Gaz RD, et al. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma[J]. Ann Surg Oncol, 2002, 9(1):57-64.
[13] Sun C, Li Q, Hu Z, et al. Treatment and prognosis of anaplastic thyroid carcinoma: experience from a single institution in china[J]. PloS one, 2013, 8(11):80011.
[14] Sherman EJ, Lim SH, Ho AL, et al. Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review[J]. Radiother Oncol, 2011, 101(3):425-430.
[15] 房居高. 强化手术技能和规范诊疗是提高甲状腺癌疗效的根本[J]. 山东大学耳鼻喉眼学报,2016, 30(2):1-4. FANG Jugao. Operation skill and standard diagnosis and treatment are the basics of improving the curative effect of thyroid carcinoma[J]. J Otolaryngol Ophthal Shandong Univ, 2016, 30(2):1-4.
[16] Zhou M, Chen Y, Adachi M, et al. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer[J]. Biomaterials, 2015, 57:41-49.
[17] Bhatia A, Rao A, Ang KK, et al. Anaplastic thyroid cancer: clinical outcomes with conformal radiotherapy[J]. Head Neck, 2010, 32(7):829-836.
[18] Lowe NM, Loughran S, Slevin NJ, et al. Anaplastic thyroid cancer: the addition of systemic chemotherapy to radiotherapy led to an observed improvement in survival-a single centre experience and review of the literature[J]. Sci World J, 2014: 674583.
[19] Seto A, Sugitani I, Toda K, et al. Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases[J]. Surg Today, 2015, 45(2):221-226.
[20] Savvides P, Nagaiah G, Lavertu P, et al. Phase ii trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid[J]. Thyroid, 2013, 23(5):600-604.
[21] Wein RO, Weber RS. Anaplastic thyroid carcinoma: Palliation or treatment?[J]. Curr Opin Otolaryngol Head Neck Surg, 2011, 19(2):113-118.
[22] Pennell NA, Daniels GH, Haddad RI, et al. A phase ii study of gefitinib in patients with advanced thyroid cancer[J]. Thyroid, 2008, 18(3):317-323.
[1] 王坛,武珂,李连庆,宫丽丽. 皮下免疫治疗注射后出现全身不良反应的伴发因素及处理[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 71-74.
[2] 吴静,刘业海. 头颈部鳞状细胞癌的靶向治疗研究进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 97-102.
[3] 沈勤峰,沈小燕,朱荣强,蒋斐斐,郎军添. 鼻内镜下中鼻甲功能性部分切除治疗慢性鼻窦炎76例分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 82-85.
[4] 代亚错,李靖,万保罗,臧艳姿,黄颖铭. 个体化治疗咽喉部海绵状血管瘤二例[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 110-112.
[5] 刘义平,林远超. 负压引流防治腮腺术后涎瘘112例[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 65-67.
[6] 陈鸣,俞雪飞. 浅谈伴有变应性鼻炎的慢性鼻窦炎的治疗[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 18-22.
[7] 张桂敏,林鹏. 慢性鼻-鼻窦炎的内在型:从基础到临床[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 14-17.
[8] 覃纲,梁灼萍. 变应性真菌性鼻-鼻窦炎免疫治疗现状[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 23-26.
[9] 吴湘萍. 患者管理方式对变应性鼻炎舌下含服粉尘螨滴剂疗效的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 68-72.
[10] 高进良,年婉清,李烁. 鼻内镜手术联合鼻用糖皮质激素治疗腺样体肥大性[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 38-42.
[11] 王仙,李颖,赵博军. 息肉样脉络膜血管病变诊疗进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 103-106.
[12] 吕丹,李明霞,马兰枝,张馨元,肖浩,陈飞,刘均,李珍. 累及纵膈的头颈部丛状I型神经纤维瘤病两例[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 82-86.
[13] 陈红,曹慧玲,窦鑫,高下. 右侧鼻腔小细胞神经内分泌癌一例并文献复习[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 89-92.
[14] 敬尚林. 儿童上气道咳嗽综合征临床诊疗现状[J]. 山东大学耳鼻喉眼学报, 2017, 31(6): 87-91.
[15] 张玉波,岳丽艳,尹晓妍,吕哲,单春光. 耳鸣治疗仪联合银杏叶提取物注射液治疗突聋伴耳鸣的疗效分析[J]. 山东大学耳鼻喉眼学报, 2017, 31(5): 50-53.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 刘衍波,林雯,王秋瑜. 鼻内镜下鼻腔泪囊吻合术38例临床效果分析[J]. 山东大学耳鼻喉眼学报, 2013, 27(6): 61 -62 .
[2] 鞠宏霜,马明忠,吴海英,伊纪亮. 儿童腺样体肥大手术切除与分泌性中耳炎[J]. 山东大学耳鼻喉眼学报, 2010, 24(3): 27 .
[3] 梁送民1,郭永伟2综述,赵霞1审校. 便携式睡眠监测仪对阻塞性睡眠呼吸暂停综合征的诊断价值[J]. 山东大学耳鼻喉眼学报, 2014, 28(2): 22 -25 .
[4] 刘敏1,郭建莲1,张华2. 玻璃体手术治疗特发性黄斑前膜的临床观察[J]. 山东大学耳鼻喉眼学报, 2013, 27(5): 65 -67 .
[5] 程雷. 特异性免疫治疗是变应性鼻炎的一线疗法[J]. 山东大学耳鼻喉眼学报, 2016, 30(4): 1 -2 .
[6] 刘俊茹,高英恺,杨杨,王俊菊,刘存军. 低温等离子刀切除舌根增生性肿物40例报告[J]. 山东大学耳鼻喉眼学报, 2017, 31(2): 83 -84 .
[7] 李俏丽,李超,王薇,蔡永聪,孙荣昊,周雨秋,税春燕, 黄璐,涂静. 术后放化疗后复发并侵及侧颅底的原发性腮腺鳞状细胞癌一例[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 87 -88 .